Lower the weight slowly over 3 to 5 seconds
A.SagareA
You should contact your GP or mental health team urgently if you experience any of the following whilst taking Mounjaro: Significant changes in mood (either elevated or depressed) Increased anxiety or agitation Changes in sleep patterns (insomnia or excessive sleeping) Thoughts of self-harm or suicide (if at immediate risk, call 999 or go to A&E) Severe or persistent gastrointestinal symptoms affecting your ability to eat or take medications Signs of dehydration Symptoms of hypoglycaemia if also taking insulin or sulfonylureas (shakiness, sweating, confusion) Additionally, seek medical advice if you notice any unusual physical symptoms such as: Severe abdominal pain Persistent vomiting Signs of pancreatitis (severe upper abdominal pain radiating to the back) Symptoms of gallbladder disease (pain in the right upper abdomen, fever, jaundice) Symptoms of thyroid problems (lump in the neck, hoarseness, difficulty swallowing) Changes in vision, particularly if you have diabetic retinopathy While rare, these require prompt medical assessment
However, upon observing substantial weight loss in clinical trials, manufacturers sensed a huge business opportunity and decided to repurpose these drugs for the treatment of obesity a modern pandemic affecting most of the developed countries
CVS Caremark will reintroduce Zepbound to its commercial formularies as a preferred option beginning October 1, 2026, increasing access to GLP-1 therapies for plan sponsors that elect to cover weight management medications
